Skip navigation
Skip navigation

Optimal Adjuvant Endocrine Therapy for Early Breast Cancer

Stuart-Harris, Robin; Davis, Alison


Adjuvant endocrine therapy substantially reduces tumor recurrence and mortality in pre- and post-menopausal women with hormone receptor-positive early breast cancer but is ineffective in women with hormone receptor-negative tumors. Tamoxifen has been the

CollectionsANU Research Publications
Date published: 2010
Type: Journal article
Source: Women's Health
DOI: 10.2217/whe.10.25


File Description SizeFormat Image
01_Stuart-Harris_Optimal_Adjuvant_Endocrine_2010.pdf540.27 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  12 November 2018/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator